Evo Fund lowers stake in Modalis Therapeutics to 6.26%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-19 12:00 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 6.26%, previous report: 7.74%.